Formulary
Travoprost: Indications, Dosing, Side Effects and Interactions
Travoprost clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Travoprost: Indications, Dosing, Side Effects and Interactions
Travoprost clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Raised intra-ocular pressure in open-angle glaucoma,Ocular hypertension**
- **Adult** (To The Eye): Apply once daily, to be administered preferably in the evening.
Cautions
Angle-closure glaucoma (no experience of use); aphakia; asthma; congenital glaucoma (no experience of use); contact lens wearers; inflammatory ocular conditions (no experience of use); narrow-angle glaucoma (no experience of use); neovascular glaucoma (no experience of use); pseudophakia with torn posterior lens capsule or anterior chamber lenses; risk factors for cystoid macular oedema; risk factors for iritis; risk factors for uveitis
Side effects
Common or very common Dry eye; eye discolouration; eye discomfort; eye disorders Uncommon Cataract; cough; eye inflammation; hair changes; headache; nasal complaints; palpitations; seasonal allergy; skin reactions; throat irritation; vision disorders Rare or very rare Allergic rhinitis; arthralgia; asthenia; asthma; constipation; dizziness; dry mouth; dysphonia; dyspnoea; gastrointestinal disorders; hypertension; hypotension; madarosis; musculoskeletal pain; ophthalmic herpes simplex; oropharyngeal pain; respiratory disorder; taste altered Frequency not known Abdominal pain; anxiety; arrhythmias; chest pain; depression; diarrhoea; epistaxis; insomnia; nausea; tinnitus; urinary disorders; vertigo; vomiting
Interactions
**Other interactions (3):**
- No specific drug interaction studies have been performed with travoprost or timolol.
- There is a potential for additive effects resulting in hypotension and/or marked bradycardia when ophthalmic beta-blocker solution is administered concomitantly with oral calcium channel blockers,...
- Potentiated systemic beta blockade (e.g.
Pregnancy
Manufacturer advises avoid unless potential benefit outweighs risk-toxicity in animal studies.
Breast feeding
Present in milk in animal studies; manufacturer advises avoid.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Travoprost in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

